Rho Works with CF Patient Advocacy Group to Develop Strong Relationships with Key Sites
Situation: Phase 3 Cystic Fibrosis study
The Success: When it comes to Cystic Fibrosis studies, it is critical that CROs build and maintain strong relationships with sites. Following study start-up for a Phase 3 Cystic Fibrosis study being conducted by Rho, the Cystic Fibrosis Foundation Therapeutics Development Network (TDN) conducted a survey of participating sites to assess their satisfaction with Rho. Some of the highlights include:
- 100% of sites ranked Rho as good or excellent for 6 of the 7 questions asked. For the seventh question, 90% of sites ranked Rho as good or excellent.
- On all questions, Rho scored higher than the TDN average.
Rho is tremendous; their people put in the extra effort to get our site initiated over a weekend in order to make it easier for a participant. At this moment, they are pretty near perfect as far as I can tell.
Site response to TDN survey